Clinical trial
Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin
NCT04765137 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 21, 2021
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mild cognitive impairment